Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-9,756
Closed -$1.62M – 311
2020
Q1
$1.62M Buy
9,756
+2,098
+27% +$383K 0.5% 92
2019
Q4
$1.31M Sell
7,658
-4,012
-34% -$668K 0.29% 166
2019
Q3
$1.93M Sell
11,670
-2,212
-16% -$311K 0.51% 65
2019
Q2
$1.66M Buy
+13,882
New +$1.42M 0.41% 97
2018
Q3
– Sell
-33,504
Closed -$2.87M – 353
2018
Q2
$2.87M Sell
33,504
-3,371
-9% -$302K 0.45% 105
2018
Q1
$3.2M Sell
36,875
-2,346
-6% -$182K 0.53% 61
2017
Q4
$2.71M Sell
39,221
-506
-1% -$33.2K 0.48% 69
2017
Q3
$2.19M Buy
+39,727
New +$2.17M 0.29% 173
2016
Q4
– Sell
-65,289
Closed -$2.67M – 349
2016
Q3
$2.67M Buy
+65,289
New +$2.58M 0.36% 155

Other funds holding PODD

EAM Investors's PODD Position: Q2 2020 in Review

EAM Investors sold out of Insulet (PODD) in Q2 2020, closing a stake of 9,756 shares — an estimated $1.62M sold.

EAM Investors first reported a position in PODD in Q3 2016 and held it in 9 quarters. The position peaked at $3.2M in Q1 2018. 423 funds tracked by Wall St. Rank hold PODD as of Q2 2020.

  • EAM Investors reported no remaining Insulet position as of Q2 2020 after selling out during the quarter.
  • EAM Investors sold 9,756 Insulet shares in Q2 2020, an estimated $1.62M.
  • EAM Investors first reported a position in Insulet in Q3 2016 and held it in 9 quarters.
  • EAM Investors's Insulet position peaked at $3.2M in Q1 2018.
  • 423 funds tracked by Wall St. Rank held Insulet as of Q2 2020.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.